Arcutis Biotherapeutics, Inc. short interest in 2025
In 2025, Arcutis Biotherapeutics, Inc.'s disclosed short interest ran from 17.27% of shares outstanding on 15 Jan 2025 to 12.26% on 31 Dec 2025, a change of -5.01 percentage points. The year's high was 17.28% on 30 Jun 2025 and its low 9.85% on 28 Nov 2025, averaging 13.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.07 days on 29 Aug 2025. Full history: Arcutis Biotherapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 17.27% (15 Jan 2025)
- End of year
- 12.26% (31 Dec 2025)
- Change
- -5.01 pp
- High
- 17.28% (30 Jun 2025)
- Low
- 9.85% (28 Nov 2025)
- Average
- 13.62%
- Highest days to cover
- 14.07 (29 Aug 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 17.27% | 10.11 | results (8-K) |
| 31 Jan 2025 | 16.16% | 10.32 | |
| 14 Feb 2025 | 15.07% | 6.56 | |
| 28 Feb 2025 | 16.89% | 8.98 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 12.91% | 7.06 | |
| 31 Mar 2025 | 12.50% | 4.93 | |
| 15 Apr 2025 | 12.29% | 4.83 | |
| 30 Apr 2025 | 12.93% | 9.57 | |
| 15 May 2025 | 13.45% | 6.86 | 10-Q filed, results (8-K) |
| 30 May 2025 | 14.07% | 8.45 | |
| 13 Jun 2025 | 15.64% | 10.21 | |
| 30 Jun 2025 | 17.28% | 9.87 | |
| 15 Jul 2025 | 14.48% | 10.04 | |
| 31 Jul 2025 | 13.88% | 12.44 | |
| 15 Aug 2025 | 15.35% | 8.47 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 14.19% | 14.07 | |
| 15 Sep 2025 | 13.38% | 8.87 | |
| 30 Sep 2025 | 12.05% | 7.83 | |
| 15 Oct 2025 | 11.91% | 6.64 | |
| 31 Oct 2025 | 11.00% | 4.79 | 10-Q filed, results (8-K) |
| 14 Nov 2025 | 11.20% | 5.45 | |
| 28 Nov 2025 | 9.85% | 4.34 | |
| 15 Dec 2025 | 10.81% | 6.78 | |
| 31 Dec 2025 | 12.26% | 7.86 |
See also: Arcutis Biotherapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.